Meitheal has FDA approval for Garzulys, but can it break into America’s crowded mealtime insulin market?
FDA approval moves Meitheal’s Garzulys into the U.S. insulin aspart market, where pricing, supply and formulary access will decide uptake.
Pharma & Biotech